首页 > 最新文献

Drug development & registration最新文献

英文 中文
Development of Ocular Inserts Based on Import Substituted Poloxamer Emuxol 268 基于进口替代型聚氧乙烯醚-Emuxol 的眼用植入物的开发 268
Pub Date : 2024-01-29 DOI: 10.33380/2305-2066-2024-13-1-1510
E. Bakhrushina, A. Turaeva, D. Zhalyalova, D. A. Klimov, N. Demina, I. I. Krasnuk
Introduction. Emuxol-268 (JSC "NIOPIK", Russia) is a block copolymer produced in Russia with similar in physicochemical and biological properties to poloxamer Kolliphor® P 188 (Pluronic F68) manufactured by BASF, USA. However, a comparison of the properties of natural polymers to assess the prospects of their dosage forms has not been carried out before.Aim. The aim of the study was to demonstrate the interchangeability of auxiliary components using the example of the development of an ophthalmic drug insert by comparing the results of testing the dosage form in terms of such quality parameters as elasticity, thickness, mucoadhesion, pH, biodegradation time and irritation test (hen’s egg-chorioallantoic membrane test, HET-CAM test).Materials and methods. Poloxamers Emuxol 268 (JSC "NIOPIK", Russia) and Kolliphor® P 188 (BASF, Germany), hydroxyethyl cellulose (Natrosol™ 250 HHX, Ashland Global Holdings Inc., USA), and glycerol (LLC "Tulskaya Pharmfabrika", Russia) were used in the experiment. Elasticity, thickness, mucoadhesion, pH, biodegradation time, HET-CAM test were used as screening methods to identify the benefits of the composition.Results and discussion. Experiment results proved that the use of a domestic analogue makes it possible to create an ocular insert with improved quality parameters. The difference in the elasticity index of the inserts differs by 1.3 times, mucoadhesion – 1.7 times, biodegradation time – 2.5 times. In this connection, it can be assumed that an insert based on a domestic polymer contributes to an increase in the time of contact with the eye surface, thereby providing a prolonged effect of the drug and improving its bioavailability. The results obtained may be due to the difference in the average molecular weight of the hydrophobic polyoxypropylene part, which is 2600 Da for Emuxol 268 and 1800 Da for Kolliphor 188. The HET-CAM method showed the same results of the two compositions, both compositions do not have an irritating effect.Conclusion. Summing up, the only analogue of Kolliphor® P 188 available on the Russian pharmaceutical market – Emuxol-268 of JSC NIOPIK is a promising substance for replacement in the development of ophthalmic dosage forms. Despite the differences in physicochemical properties of the domestic block copolymer in comparison with the replaced poloxamer 188, its introduction into placebo inserts gave improved results in terms of quality indicators, which was revealed during a biopharmaceutical analysis.
简介。Emuxol-268(俄罗斯 "NIOPIK "股份公司)是俄罗斯生产的一种嵌段共聚物,其物理化学和生物特性与美国巴斯夫公司生产的聚氧乙烯醚 Kolliphor® P 188(Pluronic F68)相似。然而,以前从未对天然聚合物的特性进行过比较,以评估其剂型的前景。本研究的目的是以开发眼科药物插入剂为例,通过比较弹性、厚度、粘附性、pH 值、生物降解时间和刺激试验(母鸡卵-绒毛膜试验,HET-CAM 试验)等质量参数对剂型进行测试的结果,证明辅助成分的互换性。实验中使用了多羟胺 Emuxol 268(JSC "NIOPIK",俄罗斯)和 Kolliphor® P 188(BASF,德国)、羟乙基纤维素(Natrosol™ 250 HHX,美国亚什兰全球控股公司)和甘油(LLC "Tulskaya Pharmfabrika",俄罗斯)。实验采用了弹性、厚度、粘附性、pH 值、生物降解时间、HET-CAM 试验等筛选方法来确定组合物的优点。实验结果证明,使用国产类似物可以制造出质量参数更高的眼药水。插入物的弹性指数相差 1.3 倍,粘附性相差 1.7 倍,生物降解时间相差 2.5 倍。由此可以推断,基于国产聚合物的药片有助于延长与眼球表面的接触时间,从而延长药物的作用时间并提高其生物利用率。所得结果可能是由于疏水性聚氧丙烯部分的平均分子量不同造成的,Emuxol 268 为 2600 Da,而 Kolliphor 188 为 1800 Da。HET-CAM 方法显示两种复合物的结果相同,都没有刺激作用。综上所述,俄罗斯医药市场上唯一一种 Kolliphor® P 188 的类似物--JSC NIOPIK 公司的 Emuxol-268 是一种很有前途的物质,可在眼科剂型的开发中替代 Kolliphor® P 188。尽管国产嵌段共聚物的理化性质与被替代的 poloxamer 188 相比存在差异,但将其引入安慰剂插页后,在质量指标方面取得了更好的效果,这一点在生物制药分析中得到了证实。
{"title":"Development of Ocular Inserts Based on Import Substituted Poloxamer Emuxol 268","authors":"E. Bakhrushina, A. Turaeva, D. Zhalyalova, D. A. Klimov, N. Demina, I. I. Krasnuk","doi":"10.33380/2305-2066-2024-13-1-1510","DOIUrl":"https://doi.org/10.33380/2305-2066-2024-13-1-1510","url":null,"abstract":"Introduction. Emuxol-268 (JSC \"NIOPIK\", Russia) is a block copolymer produced in Russia with similar in physicochemical and biological properties to poloxamer Kolliphor® P 188 (Pluronic F68) manufactured by BASF, USA. However, a comparison of the properties of natural polymers to assess the prospects of their dosage forms has not been carried out before.Aim. The aim of the study was to demonstrate the interchangeability of auxiliary components using the example of the development of an ophthalmic drug insert by comparing the results of testing the dosage form in terms of such quality parameters as elasticity, thickness, mucoadhesion, pH, biodegradation time and irritation test (hen’s egg-chorioallantoic membrane test, HET-CAM test).Materials and methods. Poloxamers Emuxol 268 (JSC \"NIOPIK\", Russia) and Kolliphor® P 188 (BASF, Germany), hydroxyethyl cellulose (Natrosol™ 250 HHX, Ashland Global Holdings Inc., USA), and glycerol (LLC \"Tulskaya Pharmfabrika\", Russia) were used in the experiment. Elasticity, thickness, mucoadhesion, pH, biodegradation time, HET-CAM test were used as screening methods to identify the benefits of the composition.Results and discussion. Experiment results proved that the use of a domestic analogue makes it possible to create an ocular insert with improved quality parameters. The difference in the elasticity index of the inserts differs by 1.3 times, mucoadhesion – 1.7 times, biodegradation time – 2.5 times. In this connection, it can be assumed that an insert based on a domestic polymer contributes to an increase in the time of contact with the eye surface, thereby providing a prolonged effect of the drug and improving its bioavailability. The results obtained may be due to the difference in the average molecular weight of the hydrophobic polyoxypropylene part, which is 2600 Da for Emuxol 268 and 1800 Da for Kolliphor 188. The HET-CAM method showed the same results of the two compositions, both compositions do not have an irritating effect.Conclusion. Summing up, the only analogue of Kolliphor® P 188 available on the Russian pharmaceutical market – Emuxol-268 of JSC NIOPIK is a promising substance for replacement in the development of ophthalmic dosage forms. Despite the differences in physicochemical properties of the domestic block copolymer in comparison with the replaced poloxamer 188, its introduction into placebo inserts gave improved results in terms of quality indicators, which was revealed during a biopharmaceutical analysis.","PeriodicalId":11259,"journal":{"name":"Drug development & registration","volume":"108 1-4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140490058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of Immunochemical Reactions Using Piezoquartz Immunosensor. Regeneration of the Electrode Bio-layer (Review) 使用压电石英免疫传感器检测免疫化学反应。电极生物层的再生(综述)
Pub Date : 2024-01-29 DOI: 10.33380/2305-2066-2024-13-1-1519
S. S. Gogina, E. A. Smirnova, Ya. M. Stanishevskii, A. M. Stoinova
Introduction. One of the most promising types of immunosensors is quartz crystal microbalance immunosensors (QCM immunosensors). Single-use biosensors are financially demanding, thus rendering the regeneration of the biosensor surface a pertinent issue for QCM immunosensors. Regeneration plays a pivotal role in sustaining the functionality of the sensor and enabling its reusability. In this article, "immunosensor" and "immunobiosensor" are interchangeable terms and are used to denote the same type of biosensors operating based on immunochemical interactions between antigens and antibodies.Text. This review discusses the features, operational principles, and applications of QCM immunosensors. Particular attention is directed toward the challenge of regenerating the biosensor surface as a key aspect ensuring their effective operation and the potential for multiple uses. Various regeneration methods and their advantages are examined. The reactivation of the biosensing layer on the QCM electrode secures its stability and functionality over extended periods, which is especially valuable in clinical and scientific research. The possibility of reusing the biosensor reduces material costs and waste production, aligning with ecological and economic concerns. Furthermore, the ability to analyze different analytes on the same surface fosters versatility in multiparametric investigations. It is essential to emphasize that the removal of residual analytes and the biosensor's regeneration process enhance reliability, selectivity, heightened sensitivity, and the potential for reproducible measurements.Conclusion. An analysis of scientific literature underscores the pivotal role of biosensor regeneration in maintaining functionality and reusability. The strength of the antigen-antibody interaction determines the conditions, which must be tailored individually for each antigen-antibody pair. The review thoroughly explores three primary approaches to the regeneration of piezoelectric transducers, including the use of a chemical method, oxygen plasma-based techniques, and the application of Piranha solution.
导言。最有前途的免疫传感器类型之一是石英晶体微天平免疫传感器(QCM 免疫传感器)。一次性使用的生物传感器对资金要求较高,因此生物传感器表面的再生成为 QCM 免疫传感器的一个相关问题。再生在维持传感器功能和实现其可重复使用性方面发挥着关键作用。在本文中,"免疫传感器 "和 "免疫生物传感器 "是可以互换的术语,用来表示基于抗原和抗体之间免疫化学相互作用的同一类生物传感器。这篇综述讨论了 QCM 免疫传感器的特点、工作原理和应用。其中特别关注了生物传感器表面再生的挑战,这是确保其有效运行和具有多种用途潜力的一个关键方面。本文研究了各种再生方法及其优势。QCM 电极上生物传感层的重新激活可确保其长期稳定性和功能性,这在临床和科学研究中尤为重要。生物传感器可重复使用,降低了材料成本,减少了废物的产生,符合生态和经济方面的要求。此外,在同一表面上分析不同分析物的能力也促进了多参数研究的多功能性。必须强调的是,残留分析物的去除和生物传感器的再生过程提高了可靠性、选择性、灵敏度和可重复性测量的潜力。对科学文献的分析强调了生物传感器再生在保持功能性和可重用性方面的关键作用。抗原-抗体相互作用的强度决定了条件,必须为每对抗原-抗体量身定制。本综述深入探讨了压电传感器再生的三种主要方法,包括使用化学方法、基于氧等离子体的技术和食人鱼溶液的应用。
{"title":"Detection of Immunochemical Reactions Using Piezoquartz Immunosensor. Regeneration of the Electrode Bio-layer (Review)","authors":"S. S. Gogina, E. A. Smirnova, Ya. M. Stanishevskii, A. M. Stoinova","doi":"10.33380/2305-2066-2024-13-1-1519","DOIUrl":"https://doi.org/10.33380/2305-2066-2024-13-1-1519","url":null,"abstract":"Introduction. One of the most promising types of immunosensors is quartz crystal microbalance immunosensors (QCM immunosensors). Single-use biosensors are financially demanding, thus rendering the regeneration of the biosensor surface a pertinent issue for QCM immunosensors. Regeneration plays a pivotal role in sustaining the functionality of the sensor and enabling its reusability. In this article, \"immunosensor\" and \"immunobiosensor\" are interchangeable terms and are used to denote the same type of biosensors operating based on immunochemical interactions between antigens and antibodies.Text. This review discusses the features, operational principles, and applications of QCM immunosensors. Particular attention is directed toward the challenge of regenerating the biosensor surface as a key aspect ensuring their effective operation and the potential for multiple uses. Various regeneration methods and their advantages are examined. The reactivation of the biosensing layer on the QCM electrode secures its stability and functionality over extended periods, which is especially valuable in clinical and scientific research. The possibility of reusing the biosensor reduces material costs and waste production, aligning with ecological and economic concerns. Furthermore, the ability to analyze different analytes on the same surface fosters versatility in multiparametric investigations. It is essential to emphasize that the removal of residual analytes and the biosensor's regeneration process enhance reliability, selectivity, heightened sensitivity, and the potential for reproducible measurements.Conclusion. An analysis of scientific literature underscores the pivotal role of biosensor regeneration in maintaining functionality and reusability. The strength of the antigen-antibody interaction determines the conditions, which must be tailored individually for each antigen-antibody pair. The review thoroughly explores three primary approaches to the regeneration of piezoelectric transducers, including the use of a chemical method, oxygen plasma-based techniques, and the application of Piranha solution.","PeriodicalId":11259,"journal":{"name":"Drug development & registration","volume":"80 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140486087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Luminescence Microscopy in the Identification of Closely related Species Using the Example of the Genus Persicaria Mill. 利用荧光显微镜识别近缘物种--以柿树属(Genus Persicaria Mill)为例
Pub Date : 2024-01-29 DOI: 10.33380/2305-2066-2024-13-1-1332
A. Gudkova, A. S. Chistyakova, A. I. Slivkin, A. S. Bolgov
Introduction. The issue of standardization and quality assessment of medicinal plant materials is currently one of the most important. To do this, a number of parameters are evaluated, the primary of which is the assessment of the authenticity of the analyzed plant object. The problem of identifying official species in the presence of closely related species is typical for plants belonging to the genus Persicaria Mill., among which only two species are used in medical practice and there is regulatory documentation for the herbs of these plants. The similarity of morphological and anatomical features of plant species acceptable for medical use and impurities interprets the need to use additional modern methods of analysis. One of such selective methods for diagnosing plant materials, along with the well-known and used in pharmaceutical analysis, is luminescence microscopy.Aim. The goal was to study the features of the luminescence of closely related species of the genus Persicaria Mill. to improve the process of their identification and standardization of official types of raw materials.Materials and methods. For work, 10 species of the genus Persicaria Mill. were used from families Polygonaceae Juss., most common in the Central Chernozem region: P. maculosa Gray, P. tomentósa Bicknell, P. lapathifólia Delarbre, P. nodósa Opiz, P. scábra Moldenke, P. brittingeri Opiz, P. hydropiper Delarbre, P. minor Opiz, P. amphibia Delarbre, P. amphibia var. terrestris Munshi & Javeid. The plants were cut at a height of about 15 cm from the soil during mass flowering in the summer of 2020 in the Voronezh region, dried in the shade. Previously, before the study, the plants were divided into morphological components (stems, leaves, petioles, bells, flowers, fruits), for which herbarium samples were used in dried form and individual parts were examined, straightened on a glass slide. To assess the luminescence of objects, a Micromed-3 Lum microscope (Russia) with a luminescent nozzle housing was used.Results and discussion. It was revealed that the intense fluorescence of large trichomes, the conducting system, guard cells of stomata, thickening of cell walls, and, in some species, the contents of receptacles and glands, is common to all studied species. A number of characteristic features of tissue luminescence for the studied species have been revealed: P. hydropiper has numerous brightly luminous receptacles and glands on all morphological parts. For P. maculosa, the presence of large receptacles along the veins was established for the first time. The perianth, glandules, and filiform hairs of the bell of P. brittingeri are clearly visible and have a yellowish-green luminescence. The leaf glands of P. tomentósa, unlike other species, do not have luminescence. The perianths of P. scábra and P. tomentósa have a yellowish-orange glow. The membranous trichomes are clearly visible in P. lapathifólia and stand out with a brownish tint. The largest number of long tuft
导言。药用植物材料的标准化和质量评估问题是当前最重要的问题之一。为此,需要对一系列参数进行评估,其中最主要的是对所分析植物对象真实性的评估。柿属(Persicaria Mill.)植物的典型问题是在存在近缘物种的情况下如何确定正式物种,其中只有两个物种被用于医疗实践,而且这些植物的药材都有规范性文件。可用于医疗用途的植物物种与杂质的形态和解剖特征相似,因此需要使用更多的现代分析方法。发光显微镜是诊断植物材料的选择性方法之一,也是众所周知的药物分析方法。目的是研究密切相关的柿属植物的发光特征,以改进其鉴定过程和官方原料类型的标准化。工作中使用了蓼科 Juss.中的 10 个柿属物种,它们在切尔诺泽姆中部地区最为常见:P. maculosa Gray、P. tomentósa Bicknell、P. lapathifólia Delarbre、P. nodósa Opiz、P. scábra Moldenke、P. brittingeri Opiz、P. hydropiper Delarbre、P. minor Opiz、P. amphibia Delarbre、P. amphibia var. terrestris Munshi & Javeid。2020 年夏天,在沃罗涅日地区大量开花时,在植株距土壤约 15 厘米处剪下,在阴凉处晾干。在研究之前,植物被分成不同的形态部分(茎、叶、叶柄、花铃、花、果),为此使用了标本馆的干燥样本,并在玻璃载玻片上拉直后对各个部分进行了检查。为了评估物体的发光情况,使用了带有发光喷嘴外壳的 Micromed-3 Lum 显微镜(俄罗斯)。结果表明,大毛状体、传导系统、气孔的保卫细胞、细胞壁的增厚以及某些物种的花托和腺体内容物的强烈荧光是所有研究物种的共同特征。所研究物种的组织发光有许多特征:P. hydropiper 的所有形态部位都有许多明亮发光的花托和腺体。对于 P. maculosa 而言,首次确定了沿叶脉存在大型花托。brittingeri 的花被、腺体和花铃丝状毛清晰可见,并发出黄绿色的荧光。Tomentósa 的叶腺体与其他物种不同,不发光。P. scábra 和 P. tomentósa 的花被呈黄橙色。P. lapathifólia的膜状毛状体清晰可见,呈褐色。在 P. amphibia var. terrestris 中,数量最多的长束毛状体发出明亮的绿色光芒。首次将发光显微镜方法应用于识别参数的分析和鉴定,建立了新的诊断特征并将其可视化,从而能够最准确地鉴定柿属物种。
{"title":"Luminescence Microscopy in the Identification of Closely related Species Using the Example of the Genus Persicaria Mill.","authors":"A. Gudkova, A. S. Chistyakova, A. I. Slivkin, A. S. Bolgov","doi":"10.33380/2305-2066-2024-13-1-1332","DOIUrl":"https://doi.org/10.33380/2305-2066-2024-13-1-1332","url":null,"abstract":"Introduction. The issue of standardization and quality assessment of medicinal plant materials is currently one of the most important. To do this, a number of parameters are evaluated, the primary of which is the assessment of the authenticity of the analyzed plant object. The problem of identifying official species in the presence of closely related species is typical for plants belonging to the genus Persicaria Mill., among which only two species are used in medical practice and there is regulatory documentation for the herbs of these plants. The similarity of morphological and anatomical features of plant species acceptable for medical use and impurities interprets the need to use additional modern methods of analysis. One of such selective methods for diagnosing plant materials, along with the well-known and used in pharmaceutical analysis, is luminescence microscopy.Aim. The goal was to study the features of the luminescence of closely related species of the genus Persicaria Mill. to improve the process of their identification and standardization of official types of raw materials.Materials and methods. For work, 10 species of the genus Persicaria Mill. were used from families Polygonaceae Juss., most common in the Central Chernozem region: P. maculosa Gray, P. tomentósa Bicknell, P. lapathifólia Delarbre, P. nodósa Opiz, P. scábra Moldenke, P. brittingeri Opiz, P. hydropiper Delarbre, P. minor Opiz, P. amphibia Delarbre, P. amphibia var. terrestris Munshi & Javeid. The plants were cut at a height of about 15 cm from the soil during mass flowering in the summer of 2020 in the Voronezh region, dried in the shade. Previously, before the study, the plants were divided into morphological components (stems, leaves, petioles, bells, flowers, fruits), for which herbarium samples were used in dried form and individual parts were examined, straightened on a glass slide. To assess the luminescence of objects, a Micromed-3 Lum microscope (Russia) with a luminescent nozzle housing was used.Results and discussion. It was revealed that the intense fluorescence of large trichomes, the conducting system, guard cells of stomata, thickening of cell walls, and, in some species, the contents of receptacles and glands, is common to all studied species. A number of characteristic features of tissue luminescence for the studied species have been revealed: P. hydropiper has numerous brightly luminous receptacles and glands on all morphological parts. For P. maculosa, the presence of large receptacles along the veins was established for the first time. The perianth, glandules, and filiform hairs of the bell of P. brittingeri are clearly visible and have a yellowish-green luminescence. The leaf glands of P. tomentósa, unlike other species, do not have luminescence. The perianths of P. scábra and P. tomentósa have a yellowish-orange glow. The membranous trichomes are clearly visible in P. lapathifólia and stand out with a brownish tint. The largest number of long tuft","PeriodicalId":11259,"journal":{"name":"Drug development & registration","volume":"49 20","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140487431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of the Dynamics of Diflunisal Release from a Polymer Matrix 聚合物基质释放二氟尼柳的动力学研究
Pub Date : 2024-01-29 DOI: 10.33380/2305-2066-2024-13-1-1538
P. A. Mihajlova, A. A. Adamova, Y. Generalova, P. Snetkov, S. Morozkina
Introduction. The effectiveness of diflunisal in the treatment of cardiac amyloidosis has been clinically proven. Currently, only tablet forms of diflunisal are registered in the world, however, long-term use of NSAIDs leads to characteristic side effects. Therefore, delivery systems for diflunisal (including a form for external use) are now being actively developed to reduce side effects and improve its bioavailability.Aim. Research of the dynamics of release of the active substance diflunisal from the polymer matrix of hyaluronic acid.Materials and methods. The objects of the study are diflunisal gels in hyaluronic acid with a concentration of the main substance of 0.093, 0.14, 0.19 and 0.25 %. Quantitative determination was carried out by reverse-phase HPLC using a Prontosil C18, 120-5, 75 × 2 mm chromatographic column, thermostatically controlled at 40 °C. Eluent: phosphate buffer solution (PBS) with pH 3.0 and acetonitrile (30 : 70), flow rate 0.1 ml/min. Eluates were detected at wavelengths of 230, 270, 310 nm.Results and discussion. During the work, a method (HPLC) was selected and a method for determining diflunisal in a HA matrix was developed. The delivery system under study significantly increases the solubility of diflunisal in an aqueous solution compared to the dissolution of the substance. The release of the active substance from the matrices was carried out in a phosphate buffer solution with pH 7.6. The release rate for all samples exceeded 90 % after 3 hours after the start of the experiment, with most of the active substance released within an hour.Conclusion. The data obtained suggest that the release profile is characteristic of biodegradable matrices and diffusion-controlled delivery systems. Complete extraction of diflunisal from HA was achieved using PBS with pH 7.6 as a dissolution medium.
简介二氟尼柳治疗心脏淀粉样变性的有效性已得到临床证实。然而,长期使用非甾体抗炎药会导致特有的副作用。因此,目前正在积极开发双氟尼沙的给药系统(包括外用型),以减少副作用并提高其生物利用度。研究活性物质二氟尼柳从透明质酸聚合物基质中释放的动力学。研究对象是主要物质浓度分别为 0.093%、0.14%、0.19% 和 0.25%的透明质酸中的二氟尼柳凝胶。采用反相高效液相色谱法进行定量检测,色谱柱为 Prontosil C18,120-5,75 × 2 mm,恒温温度为 40 °C。流出液为 pH 值为 3.0 的磷酸盐缓冲溶液(PBS)和乙腈(30:70),流速为 0.1 ml/min。在 230、270 和 310 nm 波长下检测洗脱液。在这项工作中,选择了一种方法(高效液相色谱法),并开发了一种测定 HA 基质中地氟尼萨的方法。与药物溶解相比,所研究的给药系统大大提高了二氟尼柳在水溶液中的溶解度。活性物质从基质中的释放是在 pH 值为 7.6 的磷酸盐缓冲溶液中进行的。实验开始 3 小时后,所有样品的释放率均超过 90%,大部分活性物质在 1 小时内释放。获得的数据表明,释放曲线是可生物降解基质和扩散控制给药系统的特征。使用 pH 值为 7.6 的 PBS 作为溶解介质可实现从 HA 中完全提取地氟尼柳。
{"title":"Study of the Dynamics of Diflunisal Release from a Polymer Matrix","authors":"P. A. Mihajlova, A. A. Adamova, Y. Generalova, P. Snetkov, S. Morozkina","doi":"10.33380/2305-2066-2024-13-1-1538","DOIUrl":"https://doi.org/10.33380/2305-2066-2024-13-1-1538","url":null,"abstract":"Introduction. The effectiveness of diflunisal in the treatment of cardiac amyloidosis has been clinically proven. Currently, only tablet forms of diflunisal are registered in the world, however, long-term use of NSAIDs leads to characteristic side effects. Therefore, delivery systems for diflunisal (including a form for external use) are now being actively developed to reduce side effects and improve its bioavailability.Aim. Research of the dynamics of release of the active substance diflunisal from the polymer matrix of hyaluronic acid.Materials and methods. The objects of the study are diflunisal gels in hyaluronic acid with a concentration of the main substance of 0.093, 0.14, 0.19 and 0.25 %. Quantitative determination was carried out by reverse-phase HPLC using a Prontosil C18, 120-5, 75 × 2 mm chromatographic column, thermostatically controlled at 40 °C. Eluent: phosphate buffer solution (PBS) with pH 3.0 and acetonitrile (30 : 70), flow rate 0.1 ml/min. Eluates were detected at wavelengths of 230, 270, 310 nm.Results and discussion. During the work, a method (HPLC) was selected and a method for determining diflunisal in a HA matrix was developed. The delivery system under study significantly increases the solubility of diflunisal in an aqueous solution compared to the dissolution of the substance. The release of the active substance from the matrices was carried out in a phosphate buffer solution with pH 7.6. The release rate for all samples exceeded 90 % after 3 hours after the start of the experiment, with most of the active substance released within an hour.Conclusion. The data obtained suggest that the release profile is characteristic of biodegradable matrices and diffusion-controlled delivery systems. Complete extraction of diflunisal from HA was achieved using PBS with pH 7.6 as a dissolution medium.","PeriodicalId":11259,"journal":{"name":"Drug development & registration","volume":"224 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140489935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Release Control of Biologically Active Substances from Simulation Model of Silicone Liners 从硅胶衬垫仿真模型看生物活性物质的释放控制
Pub Date : 2024-01-22 DOI: 10.33380/2305-2066-2024-13-1-1468
S. V. Gribanova, I. Udyanskaya, V. Yankova, T. Slonskaya, N. B. Epshtein, A. A. Zhukova, O. Plakhotnaya, V. N. Kuzina
Introduction. In modern medicine, the requirements for the quality of used materials are getting stricter. There is serious concern about bacterial and fungal contamination related to the use of silicone polymeric products, especially those that are in direct contact with human tissues and body fluids. In this regard, the issue of impregnating silicone medical products with various biologically active substances (BAS), particularly with antimicrobial properties, appears relevant.Aim. The research studies the relevance of adding BAS into silicone medical devices to improve their quality and prevent negative consequences of their use. The authors of the article aimed at proving prolonged release of the chosen BAS from silicone products during their contact with skin and the bacteriostatic effect emerging as a result of the BAS release. That required verifying the existence of BAS in the washouts from silicone disks, which, in turn, proves the fact that BAS initially distributed evenly in the volume of a silicone disk are capable of diffusing to the surface and then releasing from it under mechanical action, as well as when treating it with alcohol or alcohol-containing solutions.Materials and methods. Symdiol and bisabolol were selected as the BAS for this study due to their proved antibacterial, anti-inflammatory and moisturizing properties. Bisabolol and symdiol were used in the form of Dragosantol 100 and SymDiol 68T preparations correspondingly. Silicone disks (SDs), impregnated with BAS (0,2 % of the volume) were used as a simulation model of silicone liners. The BAS release from silicone liner models was assessed using highly sensitive chromatographic methods of thin-layer and gas-liquid chromatography.Results and discussion. The method of impregnating SDs with BAS was worked out, the optimal concentration of these substances to add them into the silicone base was selected. The release of the impregnated additives, as well as prolonged stable releasing effect, were confirmed. The data obtained during the experiment allows saying with confidence that the impregnated preparation (symdiol and bisabolol) releases from a SD even upon short and low-intensity mechanical contact with skin, which produces stable bacteriostatic effect on a wide range of microorganisms. The process of BAS release from SDs is also facilitated when treating the product periodically with alcohol-containing solutions, which is necessary according to the operating rules. The obtained results of the chromatographic research quite correlate with the data of the previous microbiological experiments regarding the studied topic. Release of the studied BAS from polymer products during their contact with the skin within the period of not less than 3 months justifies feasibility of adding these BAS into the silicone base.Conclusions. The study confirmed the release of biologically active substances from silicone medical products. Adding BAS into silicone liners undoubtedly improves
简介现代医学对所用材料的质量要求越来越严格。人们严重关注与使用硅聚合物产品有关的细菌和真菌污染问题,尤其是那些与人体组织和体液直接接触的产品。因此,在硅胶医疗产品中浸渍各种生物活性物质(BAS),特别是具有抗菌特性的物质,似乎具有现实意义。该研究探讨了在硅胶医疗器械中添加 BAS 的相关性,以提高其质量并防止其使用过程中产生负面影响。文章作者的目的是证明硅胶产品在与皮肤接触的过程中,所选 BAS 的长期释放以及 BAS 释放所产生的抑菌效果。这就需要验证硅胶盘的冲洗液中是否存在 BAS,这反过来又证明了一个事实:最初均匀分布在硅胶盘体积中的 BAS 能够扩散到表面,然后在机械作用下以及用酒精或含酒精的溶液处理硅胶盘时从表面释放出来。由于 Symdiol 和 bisabolol 具有公认的抗菌、消炎和保湿特性,因此被选为本研究的 BAS。双羟萘酸和双羟萘酸分别以 Dragosantol 100 和 SymDiol 68T 制剂的形式使用。浸渍了 BAS(占体积的 0.2%)的硅胶盘(SD)被用作硅胶衬垫的模拟模型。结果和讨论。研究了用 BAS 对 SDs 进行浸渍的方法,并选择了将这些物质添加到硅胶基材中的最佳浓度。实验证实了浸渍添加剂的释放效果以及长期稳定的释放效果。根据实验中获得的数据,我们可以肯定地说,浸渍制剂(symdiol 和 bisabolol)即使在与皮肤进行短时间和低强度的机械接触时也会从 SD 中释放出来,从而对多种微生物产生稳定的抑菌作用。根据操作规定,定期用含酒精的溶液处理 SD 产品也有助于 BAS 的释放过程。色谱研究的结果与之前有关研究主题的微生物实验数据十分吻合。在不少于 3 个月的时间内,所研究的 BAS 会在聚合物产品与皮肤接触的过程中释放出来,这证明在硅酮基料中添加这些 BAS 是可行的。研究证实了硅胶医疗产品中生物活性物质的释放。在硅胶衬里中添加 BAS 无疑会提高这些医疗产品的质量,这些产品可用于假肢和矫形器。
{"title":"Release Control of Biologically Active Substances from Simulation Model of Silicone Liners","authors":"S. V. Gribanova, I. Udyanskaya, V. Yankova, T. Slonskaya, N. B. Epshtein, A. A. Zhukova, O. Plakhotnaya, V. N. Kuzina","doi":"10.33380/2305-2066-2024-13-1-1468","DOIUrl":"https://doi.org/10.33380/2305-2066-2024-13-1-1468","url":null,"abstract":"Introduction. In modern medicine, the requirements for the quality of used materials are getting stricter. There is serious concern about bacterial and fungal contamination related to the use of silicone polymeric products, especially those that are in direct contact with human tissues and body fluids. In this regard, the issue of impregnating silicone medical products with various biologically active substances (BAS), particularly with antimicrobial properties, appears relevant.Aim. The research studies the relevance of adding BAS into silicone medical devices to improve their quality and prevent negative consequences of their use. The authors of the article aimed at proving prolonged release of the chosen BAS from silicone products during their contact with skin and the bacteriostatic effect emerging as a result of the BAS release. That required verifying the existence of BAS in the washouts from silicone disks, which, in turn, proves the fact that BAS initially distributed evenly in the volume of a silicone disk are capable of diffusing to the surface and then releasing from it under mechanical action, as well as when treating it with alcohol or alcohol-containing solutions.Materials and methods. Symdiol and bisabolol were selected as the BAS for this study due to their proved antibacterial, anti-inflammatory and moisturizing properties. Bisabolol and symdiol were used in the form of Dragosantol 100 and SymDiol 68T preparations correspondingly. Silicone disks (SDs), impregnated with BAS (0,2 % of the volume) were used as a simulation model of silicone liners. The BAS release from silicone liner models was assessed using highly sensitive chromatographic methods of thin-layer and gas-liquid chromatography.Results and discussion. The method of impregnating SDs with BAS was worked out, the optimal concentration of these substances to add them into the silicone base was selected. The release of the impregnated additives, as well as prolonged stable releasing effect, were confirmed. The data obtained during the experiment allows saying with confidence that the impregnated preparation (symdiol and bisabolol) releases from a SD even upon short and low-intensity mechanical contact with skin, which produces stable bacteriostatic effect on a wide range of microorganisms. The process of BAS release from SDs is also facilitated when treating the product periodically with alcohol-containing solutions, which is necessary according to the operating rules. The obtained results of the chromatographic research quite correlate with the data of the previous microbiological experiments regarding the studied topic. Release of the studied BAS from polymer products during their contact with the skin within the period of not less than 3 months justifies feasibility of adding these BAS into the silicone base.Conclusions. The study confirmed the release of biologically active substances from silicone medical products. Adding BAS into silicone liners undoubtedly improves ","PeriodicalId":11259,"journal":{"name":"Drug development & registration","volume":"66 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139606543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Doxorubicin in the Formation of Cardiotoxicity – Generally Accepted Statement. Part I. Prevalence and Mechanisms of Formation (Review) 多柔比星在形成心脏毒性中的作用--公认声明。第一部分:发病率和形成机制(综述)
Pub Date : 2024-01-19 DOI: 10.33380/2305-2066-2024-13-1-1508
D. A. Andreev, E. I. Balakin, A. S. Samoilov, V. I. Pustovoit
Introduction. Long-term use of anthracyclines during cancer chemotherapy has been associated with the development of potentially life-threatening cardiotoxicity. Despite researches ongoing since the middle of the last century, approaches to the choice of therapy remain limited.Text. Doxorubicin currently is the most widely used chemotherapy. The leading side effect mechanism of the drug is the formation of reactive oxygen species in mitochondria with the mediated development of oxidative stress, which contributes to myocardial damage. However, despite the huge number of scientific papers devoted to various aspects of doxorubicin cardiotoxicity, its prevention and treatment, this issue requires detailed investigation in order to develop more advanced methods for early diagnosis and timely cardioprotective therapy.Conclusion. The current review discusses the pathogenetic mechanisms of cardiotoxicity associated with the use of doxorubicin chemotherapy. The pathogenesis of the cardiomyocytes death mechanism will provide an opportunity to develop new diagnostic and therapeutic approaches in the clinical practice.
简介。在癌症化疗过程中长期使用蒽环类药物可能会引发危及生命的心脏毒性。尽管自上世纪中叶以来,相关研究一直在进行,但治疗方法的选择仍然有限。多柔比星是目前使用最广泛的化疗药物。该药物的主要副作用机制是在线粒体中形成活性氧,介导氧化应激的发展,从而导致心肌损伤。然而,尽管有大量科学论文致力于研究多柔比星心脏毒性、其预防和治疗的各个方面,但这一问题仍需要详细研究,以便开发出更先进的早期诊断和及时心脏保护治疗方法。本综述讨论了与使用多柔比星化疗相关的心脏毒性的发病机制。心肌细胞死亡的发病机制将为临床实践中开发新的诊断和治疗方法提供契机。
{"title":"The Role of Doxorubicin in the Formation of Cardiotoxicity – Generally Accepted Statement. Part I. Prevalence and Mechanisms of Formation (Review)","authors":"D. A. Andreev, E. I. Balakin, A. S. Samoilov, V. I. Pustovoit","doi":"10.33380/2305-2066-2024-13-1-1508","DOIUrl":"https://doi.org/10.33380/2305-2066-2024-13-1-1508","url":null,"abstract":"Introduction. Long-term use of anthracyclines during cancer chemotherapy has been associated with the development of potentially life-threatening cardiotoxicity. Despite researches ongoing since the middle of the last century, approaches to the choice of therapy remain limited.Text. Doxorubicin currently is the most widely used chemotherapy. The leading side effect mechanism of the drug is the formation of reactive oxygen species in mitochondria with the mediated development of oxidative stress, which contributes to myocardial damage. However, despite the huge number of scientific papers devoted to various aspects of doxorubicin cardiotoxicity, its prevention and treatment, this issue requires detailed investigation in order to develop more advanced methods for early diagnosis and timely cardioprotective therapy.Conclusion. The current review discusses the pathogenetic mechanisms of cardiotoxicity associated with the use of doxorubicin chemotherapy. The pathogenesis of the cardiomyocytes death mechanism will provide an opportunity to develop new diagnostic and therapeutic approaches in the clinical practice.","PeriodicalId":11259,"journal":{"name":"Drug development & registration","volume":"80 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139612826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasonic Activation of Mineral Sorbents 矿物吸附剂的超声波活化
Pub Date : 2024-01-19 DOI: 10.33380/2305-2066-2024-13-1-1630
A. V. Bondarev, E. T. Zhilyakova, N. Avtina, N. Demina, K. K. Razmakhnin
Introduction. Medical clays are polymineral sorbents with a predominance of the underlying clay mineral, the concentration of which determines the quality of mineral raw materials and its adsorption activity. One of the methods of improving the quality of mineral raw materials is its activation by means of ultrasonic treatment.Aim. To study the effect of ultrasound on the activation and adsorption activity of mineral sorbents.Materials and methods. Clinoptilolite mineral raw materials of the Kholinsky deposit, montmorillonite mineral raw materials of the Belgorod deposit and kaolinite mineral raw materials of the Eleninsky deposit were used as objects of research. A high-frequency UZDN-1 unit was used for ultrasonic treatment. Determination of adsorption activity was carried out by methylene blue.Results and discussion. The effect of ultrasound on the activation of mineral sorbents at an ultrasonic wave frequency of 40 kHz for five minutes has been studied. It was found that the average content of Clinoptilolite, taking into account all fractions in the clay of the Kholinsky deposit, increases by 20 %, the average content of Montmorillonite, taking into account all fractions in the clay of the Belgorod deposit, increases by 14 %, the average content of Kaolinite, taking into account all fractions in the clay of the Eleninsky deposit, increases by 18 %. The effect of ultrasound on the adsorption activity of mineral sorbents has been investigated. The use of ultrasonic treatment increases the adsorption activity of mineral sorbents by 12–19 %.Conclusion. The developed method of activation of mineral sorbents by ultrasonic treatment can be used to activate mineral sorbents by increasing the concentration of the underlying mineral (Clinoptilolite, Montmorillonite, Kaolinite), as well as increasing their adsorption activity.
导言。医用粘土是一种多矿物吸附剂,其主要成分是粘土矿物,粘土矿物的浓度决定了矿物原料的质量及其吸附活性。通过超声波处理活化矿物原料是提高矿物原料质量的方法之一。研究超声波对矿物吸附剂活化和吸附活性的影响。研究对象为霍林斯基矿床的霞石矿物原料、别尔哥罗德矿床的蒙脱石矿物原料和叶连宁斯基矿床的高岭石矿物原料。高频 UZDN-1 设备用于超声波处理。结果和讨论。在超声波频率为 40 kHz、持续 5 分钟的条件下,研究了超声波对矿物吸附剂活化的影响。研究发现,考虑到霍林斯基矿床粘土的所有组分,霞石的平均含量增加了 20%;考虑到别尔哥罗德矿床粘土的所有组分,蒙脱石的平均含量增加了 14%;考虑到叶连宁斯基矿床粘土的所有组分,高岭石的平均含量增加了 18%。研究了超声波对矿物吸附剂吸附活性的影响。使用超声波处理可使矿物吸附剂的吸附活性提高 12-19%。所开发的通过超声波处理活化矿物吸附剂的方法可用于活化矿物吸附剂,提高底层矿物(霞石、蒙脱石、高岭石)的浓度,并提高其吸附活性。
{"title":"Ultrasonic Activation of Mineral Sorbents","authors":"A. V. Bondarev, E. T. Zhilyakova, N. Avtina, N. Demina, K. K. Razmakhnin","doi":"10.33380/2305-2066-2024-13-1-1630","DOIUrl":"https://doi.org/10.33380/2305-2066-2024-13-1-1630","url":null,"abstract":"Introduction. Medical clays are polymineral sorbents with a predominance of the underlying clay mineral, the concentration of which determines the quality of mineral raw materials and its adsorption activity. One of the methods of improving the quality of mineral raw materials is its activation by means of ultrasonic treatment.Aim. To study the effect of ultrasound on the activation and adsorption activity of mineral sorbents.Materials and methods. Clinoptilolite mineral raw materials of the Kholinsky deposit, montmorillonite mineral raw materials of the Belgorod deposit and kaolinite mineral raw materials of the Eleninsky deposit were used as objects of research. A high-frequency UZDN-1 unit was used for ultrasonic treatment. Determination of adsorption activity was carried out by methylene blue.Results and discussion. The effect of ultrasound on the activation of mineral sorbents at an ultrasonic wave frequency of 40 kHz for five minutes has been studied. It was found that the average content of Clinoptilolite, taking into account all fractions in the clay of the Kholinsky deposit, increases by 20 %, the average content of Montmorillonite, taking into account all fractions in the clay of the Belgorod deposit, increases by 14 %, the average content of Kaolinite, taking into account all fractions in the clay of the Eleninsky deposit, increases by 18 %. The effect of ultrasound on the adsorption activity of mineral sorbents has been investigated. The use of ultrasonic treatment increases the adsorption activity of mineral sorbents by 12–19 %.Conclusion. The developed method of activation of mineral sorbents by ultrasonic treatment can be used to activate mineral sorbents by increasing the concentration of the underlying mineral (Clinoptilolite, Montmorillonite, Kaolinite), as well as increasing their adsorption activity.","PeriodicalId":11259,"journal":{"name":"Drug development & registration","volume":"20 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139613618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomarkers of Brain Ischemia (Review) 脑缺血的生物标志物(综述)
Pub Date : 2024-01-19 DOI: 10.33380/2305-2066-2024-13-1-1478
A. Samoylov, E. I. Balakin, V. I. Pustovoit
Introduction. Strokes remain the second leading cause of death and the third leading cause of disability. Additional serum biomarker testing should be used to better diagnose transient ischemic attack (TIA), but most neurospecific biomarkers have low prognostic specificity and sensitivity. Timely identification of TIA and differential diagnosis of stroke in the first hour will ensure a shorter period of patient recovery and reduce the risk of mortality and disability. Serum biomarker studies should be included to overcome the difficulty of diagnosing TIA.Text. Neurospecific biomarkers such as S100B, GFAP, and NSE are used to diagnose acute ischemic damage to glial cells and neurons. S100B and GFAP are detected in astrocytes and NSE in neurons and cells of the neuroendocrine system. Elevated serum concentrations of these biomarkers are associated with various pathological conditions such as strokes and brain injuries and other central nervous system (CNS) lesions. Dynamic monitoring of biomarker concentrations makes it possible to evaluate the efficacy of the ongoing therapy and to identify predictors of patient deterioration for prompt correction of therapeutic procedures. To create a diagnostic panel it is necessary to study metabolic processes in ischemic tissue, taking into account concomitant diagnoses and results of neuroimaging, and to use breakthrough advances in machine learning and big data.Conclusion. The review showed that none of the assessed biomarkers can be recommended for the diagnosis of cerebral circulation disorders, but the combination of several neurospecific biomarkers can significantly improve diagnostic efficiency and find application in the differential diagnosis of stroke, intracranial hematoma, and other brain lesions for the purpose of early pharmacotherapy of CNS lesions and as surrogate endpoints during clinical trials.
导言。脑卒中仍然是导致死亡的第二大原因和导致残疾的第三大原因。为更好地诊断短暂性脑缺血发作(TIA),应使用额外的血清生物标志物检测,但大多数神经特异性生物标志物的预后特异性和敏感性较低。在第一时间及时发现 TIA 并鉴别诊断卒中可确保缩短患者的恢复期,降低死亡和残疾风险。应纳入血清生物标志物研究,以克服诊断 TIA 的困难。S100B、GFAP 和 NSE 等神经特异性生物标志物可用于诊断神经胶质细胞和神经元的急性缺血性损伤。S100B 和 GFAP 可在星形胶质细胞中检测到,NSE 可在神经元和神经内分泌系统细胞中检测到。这些生物标记物的血清浓度升高与中风、脑损伤和其他中枢神经系统(CNS)病变等各种病理情况有关。对生物标志物浓度进行动态监测,可以评估正在进行的治疗的疗效,并确定病人病情恶化的预测因素,以便及时纠正治疗程序。要建立一个诊断面板,就必须研究缺血组织的代谢过程,同时考虑到伴随的诊断和神经影像学结果,并利用机器学习和大数据方面的突破性进展。综述显示,没有一种评估的生物标志物可推荐用于诊断脑循环障碍,但几种神经特异性生物标志物的组合可显著提高诊断效率,并可应用于中风、颅内血肿和其他脑部病变的鉴别诊断,以便对中枢神经系统病变进行早期药物治疗,并在临床试验中作为替代终点。
{"title":"Biomarkers of Brain Ischemia (Review)","authors":"A. Samoylov, E. I. Balakin, V. I. Pustovoit","doi":"10.33380/2305-2066-2024-13-1-1478","DOIUrl":"https://doi.org/10.33380/2305-2066-2024-13-1-1478","url":null,"abstract":"Introduction. Strokes remain the second leading cause of death and the third leading cause of disability. Additional serum biomarker testing should be used to better diagnose transient ischemic attack (TIA), but most neurospecific biomarkers have low prognostic specificity and sensitivity. Timely identification of TIA and differential diagnosis of stroke in the first hour will ensure a shorter period of patient recovery and reduce the risk of mortality and disability. Serum biomarker studies should be included to overcome the difficulty of diagnosing TIA.Text. Neurospecific biomarkers such as S100B, GFAP, and NSE are used to diagnose acute ischemic damage to glial cells and neurons. S100B and GFAP are detected in astrocytes and NSE in neurons and cells of the neuroendocrine system. Elevated serum concentrations of these biomarkers are associated with various pathological conditions such as strokes and brain injuries and other central nervous system (CNS) lesions. Dynamic monitoring of biomarker concentrations makes it possible to evaluate the efficacy of the ongoing therapy and to identify predictors of patient deterioration for prompt correction of therapeutic procedures. To create a diagnostic panel it is necessary to study metabolic processes in ischemic tissue, taking into account concomitant diagnoses and results of neuroimaging, and to use breakthrough advances in machine learning and big data.Conclusion. The review showed that none of the assessed biomarkers can be recommended for the diagnosis of cerebral circulation disorders, but the combination of several neurospecific biomarkers can significantly improve diagnostic efficiency and find application in the differential diagnosis of stroke, intracranial hematoma, and other brain lesions for the purpose of early pharmacotherapy of CNS lesions and as surrogate endpoints during clinical trials.","PeriodicalId":11259,"journal":{"name":"Drug development & registration","volume":"44 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139612024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective Analysis of Polyethylene Oxide and Polypropylene Oxide Block Copolymers Production and Industrial Applications (Review) 聚氧化乙烯和聚氧化丙烯嵌段共聚物生产和工业应用回顾分析(综述)
Pub Date : 2024-01-19 DOI: 10.33380/2305-2066-2024-13-1-1400
E. Bakhrushina, V. S. Pyzhov, P. Sakharova, N. Demina, I. Krasnyuk
Introduction. Nowadays block copolymers of PEO and PPO (poloxamers, pluronics, proxanols) are among the most popular polymers in the pharmaceutical and biotechnological industries. They can be applied as effective nonionic surfactants, biological membrane stabilizers, elements of targeted delivery systems, solubilizers, as well as excipients in the technology of traditional dosage forms – gelling agents, lubricants, etc. For the past fifty years, the world's largest manufacturer of poloxamers has been the German chemical concern BASF. However, today in the Russian Federation there is a risk of defects, which defines the relevance of import substitution of this excipient.Text. The purpose of this review is to highlight the experience of production and implementation of PEO and PPO block copolymers into novel Russian scientists’ developments, comparing them with the experience of foreign research groups, which is necessary to assess the potential for import substitution. PEO and PPO block copolymers have been known in the Soviet Union since the late 60s as far as they are mentioned in textbooks of 1964 and 1973. Domestic block copolymers of PEO and PPO have been used in the oil refining industry, as well as in some branches of light industry and in the decontamination of radioactive waste. The unique domestic synthesis of PEO and PPO block copolymers was established in 1978 on the basis of the "Orgsintez" factory. Soviet poloxamers were produced under the brand name "proxanol" in a wide range of ratios of EO and PO units and molecular weights. It should be noted that today in the Russian Federation, industrial batches of the solubilizer Emuxol 268, which is close in its properties to the well-known poloxamer 188, are still produced, and block copolymers with other ratios of EO and PO units are synthesized to order.Conclusion. According to the retrospective analysis, the modern Russian industry has enough experience and resources to establish the synthesis of PEO and PPO block copolymers necessary to produce drugs and to develop innovative delivery systems and drugs. Based on the materials of the systematic review, the most complete register of known brands of PEO and PPO block copolymers synthesized over the past 50 years in our country and in the world was compiled for the first time, with a detailed description of their physicochemical properties.
简介。如今,PEO 和 PPO 嵌段共聚物(poloxamers、pluronics、proxanols)是制药和生物技术行业最受欢迎的聚合物之一。它们可用作有效的非离子表面活性剂、生物膜稳定剂、靶向给药系统元件、增溶剂以及传统剂型技术中的赋形剂--胶凝剂、润滑剂等。过去五十年来,世界上最大的多羟酰胺生产商一直是德国巴斯夫化学公司。然而,如今在俄罗斯联邦存在着缺陷风险,这就决定了进口替代这种辅料的重要性。本综述的目的是重点介绍俄罗斯科学家在新型 PEO 和 PPO 嵌段共聚物的生产和应用方面的经验,并将其与国外研究小组的经验进行比较,这对于评估进口替代的潜力非常必要。苏联早在 60 年代末期就已经知道 PEO 和 PPO 嵌段共聚物,1964 年和 1973 年的教科书中都有提及。国内的 PEO 和 PPO 嵌段共聚物已用于炼油工业、轻工业的某些部门以及放射性废物的净化。1978 年,在 "Orgsintez "工厂的基础上建立了国内独一无二的 PEO 和 PPO 嵌段共聚物合成技术。苏联以 "proxanol "为商标生产聚氧化酰胺,其 EO 和 PO 单位的比例和分子量范围很广。值得注意的是,如今在俄罗斯联邦,仍在生产工业批量生产的增溶剂 Emuxol 268(其性质与著名的聚氧乙烯酰胺 188 相似),并根据订单合成具有其他 EO 和 PO 单元比例的嵌段共聚物。根据回顾性分析,现代俄罗斯工业拥有足够的经验和资源来合成生产药物和开发创新给药系统和药物所需的 PEO 和 PPO 嵌段共聚物。在系统回顾材料的基础上,首次汇编了我国和世界上在过去 50 年中合成的 PEO 和 PPO 嵌段共聚物已知品牌的最完整登记册,并详细描述了它们的物理化学特性。
{"title":"Retrospective Analysis of Polyethylene Oxide and Polypropylene Oxide Block Copolymers Production and Industrial Applications (Review)","authors":"E. Bakhrushina, V. S. Pyzhov, P. Sakharova, N. Demina, I. Krasnyuk","doi":"10.33380/2305-2066-2024-13-1-1400","DOIUrl":"https://doi.org/10.33380/2305-2066-2024-13-1-1400","url":null,"abstract":"Introduction. Nowadays block copolymers of PEO and PPO (poloxamers, pluronics, proxanols) are among the most popular polymers in the pharmaceutical and biotechnological industries. They can be applied as effective nonionic surfactants, biological membrane stabilizers, elements of targeted delivery systems, solubilizers, as well as excipients in the technology of traditional dosage forms – gelling agents, lubricants, etc. For the past fifty years, the world's largest manufacturer of poloxamers has been the German chemical concern BASF. However, today in the Russian Federation there is a risk of defects, which defines the relevance of import substitution of this excipient.Text. The purpose of this review is to highlight the experience of production and implementation of PEO and PPO block copolymers into novel Russian scientists’ developments, comparing them with the experience of foreign research groups, which is necessary to assess the potential for import substitution. PEO and PPO block copolymers have been known in the Soviet Union since the late 60s as far as they are mentioned in textbooks of 1964 and 1973. Domestic block copolymers of PEO and PPO have been used in the oil refining industry, as well as in some branches of light industry and in the decontamination of radioactive waste. The unique domestic synthesis of PEO and PPO block copolymers was established in 1978 on the basis of the \"Orgsintez\" factory. Soviet poloxamers were produced under the brand name \"proxanol\" in a wide range of ratios of EO and PO units and molecular weights. It should be noted that today in the Russian Federation, industrial batches of the solubilizer Emuxol 268, which is close in its properties to the well-known poloxamer 188, are still produced, and block copolymers with other ratios of EO and PO units are synthesized to order.Conclusion. According to the retrospective analysis, the modern Russian industry has enough experience and resources to establish the synthesis of PEO and PPO block copolymers necessary to produce drugs and to develop innovative delivery systems and drugs. Based on the materials of the systematic review, the most complete register of known brands of PEO and PPO block copolymers synthesized over the past 50 years in our country and in the world was compiled for the first time, with a detailed description of their physicochemical properties.","PeriodicalId":11259,"journal":{"name":"Drug development & registration","volume":"99 44","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139612367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gefitinib: Combination Therapy and Complex Delivery Systems (Review) 吉非替尼:吉非替尼:联合疗法和复合给药系统(综述)
Pub Date : 2024-01-12 DOI: 10.33380/2305-2066-2024-13-1-1615
L. Nikolaeva, E. Sanarova, A. Lantsova
Introduction. The search for new methods of therapy for non-small cell lung cancer (NSCLC) is an urgent task of modern science. Gefitinib is a targeted drug widely used in the treatment of NSCLC in patients with a mutation in the epidermal growth factor receptor tyrosine kinase domain. However, using of gefitinib and other drugs from the group of tyrosine kinase inhibitors is to limited by rapidly developing resistance, for this reason finding of a ways overcome drug resistance is actual part of research interests.Text. The review is devoted to the use of gefitinib in modern developments: introduction to various targeted delivery systems (liposomes, micelles, microspheres, etc.), studying it in combination with other chemotherapeutic agents, as well as in combination with photo- or thermosensitive compounds in various micro- and nanostructured complexes.Conclusion. As a result of the analysis of literature data, it was shown that, despite the fact that gefitinib is a first-generation drug, foreign and Russian researchers consider it quite promising for further use in the treatment of NSCLC. At the same time, developments are being carried out both in the field of expanding combination therapy and in the field of creating complex structures of targeted action, into which, in addition to gefitinib, photosensitizers or other compounds with photo- or thermosensitive effects are introduced.
简介:寻找治疗非小细胞肺癌(NSCLC)的新方法是现代科学的迫切任务。寻找治疗非小细胞肺癌(NSCLC)的新方法是现代科学的一项紧迫任务。吉非替尼是一种靶向药物,被广泛用于治疗表皮生长因子受体酪氨酸激酶结构域发生突变的非小细胞肺癌患者。然而,吉非替尼和其他酪氨酸激酶抑制剂类药物的使用受到快速发展的耐药性的限制,因此寻找克服耐药性的方法成为研究兴趣的实际部分。这篇综述主要介绍了吉非替尼在现代发展中的应用:介绍各种靶向给药系统(脂质体、胶束、微球等),研究它与其他化疗药物的联合应用,以及在各种微纳米结构复合物中与光敏或热敏化合物的联合应用。对文献数据的分析结果表明,尽管吉非替尼是第一代药物,但外国和俄罗斯的研究人员认为它很有希望进一步用于治疗 NSCLC。与此同时,在扩大联合疗法领域和建立复杂的靶向作用结构领域都取得了进展,除吉非替尼外,还引入了光敏剂或其他具有光敏或热敏作用的化合物。
{"title":"Gefitinib: Combination Therapy and Complex Delivery Systems (Review)","authors":"L. Nikolaeva, E. Sanarova, A. Lantsova","doi":"10.33380/2305-2066-2024-13-1-1615","DOIUrl":"https://doi.org/10.33380/2305-2066-2024-13-1-1615","url":null,"abstract":"Introduction. The search for new methods of therapy for non-small cell lung cancer (NSCLC) is an urgent task of modern science. Gefitinib is a targeted drug widely used in the treatment of NSCLC in patients with a mutation in the epidermal growth factor receptor tyrosine kinase domain. However, using of gefitinib and other drugs from the group of tyrosine kinase inhibitors is to limited by rapidly developing resistance, for this reason finding of a ways overcome drug resistance is actual part of research interests.Text. The review is devoted to the use of gefitinib in modern developments: introduction to various targeted delivery systems (liposomes, micelles, microspheres, etc.), studying it in combination with other chemotherapeutic agents, as well as in combination with photo- or thermosensitive compounds in various micro- and nanostructured complexes.Conclusion. As a result of the analysis of literature data, it was shown that, despite the fact that gefitinib is a first-generation drug, foreign and Russian researchers consider it quite promising for further use in the treatment of NSCLC. At the same time, developments are being carried out both in the field of expanding combination therapy and in the field of creating complex structures of targeted action, into which, in addition to gefitinib, photosensitizers or other compounds with photo- or thermosensitive effects are introduced.","PeriodicalId":11259,"journal":{"name":"Drug development & registration","volume":"3 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139532365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Drug development & registration
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1